ASCO Explained: Expert predictions for the world’s biggest cancer meeting

Jill O'Donnell-Tormey, CEO and Director of Scientific Affairs, is a panelist for the Fierce BioTech virtual roundtable.

Cancer experts will highlight closely watched data sets to be unveiled at ASCO. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2021's biggest research trends, and the data they're most looking forward to seeing.

Moderator:

Annalee Armstrong
Senior Editor
FierceBiotech

Panelists:

Jill O’Donnell-Tormey, PhD
Chief Executive Officer and Director of Scientific Affairs
Cancer Research Institute 

Jennifer Keating Litton, MD
Vice President of Clinical Research and Professor
The University of Texas MD Anderson Cancer Center

Joseph Alvarnas, MD
Vice President for Government Affairs, Chief Clinical Advisor
AccessHope
Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation
City of Hope

 

Photo by Wolfgang Hasselmann on Unsplash
  

Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son